SEARCH RESULTS FOR:

United States
Pharma & Life Sciences

Jeffrey Nau

PRESIDENT & CEO, OYSTER POINT PHARMA
"Our mission is to bring novel and transformative therapies to the anterior (front) chamber of the eye, particularly for the treatment of ocular surface disease."
United States
Pharma & Life Sciences

Shuang Liu

CEO & FOUNDER, CONSYNANCE THERAPEUTICS
"Although each rare disease impacts a small population, the rare disease population is estimated to be 10% of the total population, meaning 25-30 million Americans have at least one rare condition."
Petrochemicals & Chemicals
Singapore

Vinod Agnihotri

MANAGING DIRECTOR ASEAN AND HEAD OF MPP, APAC LANXESS
"The strong recovery in the automotive sector has contributed significantly to our growth, and so did our engineering materials segment, which includes both our high-performance materials and urethane systems business units."
Mining
Chile

Marcela Hernando

MINISTER OF MINING, GOVERNMENT OF CHILE
“We would like exploration to open the door to new developments, so we aim to make the necessary regulatory changes to increase legal certainty for those who are willing to invest in exploration.”
Mining
Chile

Mario Theurl

MANAGING DIRECTOR, ZÜBLIN STRABAG CHILE
“I am convinced that our appreciation towards our great teams with open and transparent communication and our customer centricity are key to success.”
Mining
Peru
SPANISH

Jorge Granda

COO, AK DRILLING INTERNATIONAL
AK Drilling discusses the current state of the drilling sector in Peru. (Spanish interview)
Mining
Peru
SPANISH

José Luis Lara

GERENTE GENERAL, LARA CONSULTING
Lara Consulting provides an overview of its expertise in tailings management. (Spanish interview)
Petrochemicals & Chemicals
Singapore

Takayuki Inagaki

MANAGING DIRECTOR, MITSUI CHEMICALS ASIA PACIFIC (MCAP)
"MCAP is committed to continue our support to Mitsui Chemicals Group in moving towards a solution-based business model to respond to social and environmental challenges."
United States
Pharma & Life Sciences

Jay Roberts & Robert Fremeau

PRESIDENT AND CEO & CHIEF SCIENTIFIC OFFICER, VYANT BIO
"At Vyant Bio we are reinventing how drugs are discovered for complex neurological and neurodegenerative disorders by applying a human-first approach."
United States
Pharma & Life Sciences

Andrea Pfeifer

CO-FOUNDER & CEO, AC IMMUNE
"AC Immune is combining diagnostics and therapeutics, and it has developed the tools to enable detection and clearance of specific pathological proteins underlying neurodegenerative diseases."

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

United States Life Sciences 2025 - Digital Interactive

Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
MORE PREVIOUSLY PUBLISHED

PARTNER EVENTS

SEE ALL